| 書目名稱 | Fibrin Sealant in Operative Medicine | | 副標(biāo)題 | Volume 5: Thoracic S | | 編輯 | Günther Schlag,Heinz Redl | | 視頻video | http://file.papertrans.cn/343/342501/342501.mp4 | | 圖書封面 |  | | 描述 | Fibrin plays a prominent role in wound healing. It has a hemostatic effect, induces cellular response to wound damage, and, by forming strands to build a matrix, assists in neovascularization and fibroblast proliferation. The concept of using clotting substances from human blood for wound manage- ment and to achieve hemostasis in bleeding parenchymatous organs can be traced to 1909, when Bergel [1] reported on the hemostatic effect of fibrin powder. In 1915, Grey [3] employed fibrin to control bleeding in neurosurgical operations of the brain. A year later, Harvey [4] used fibrin patches to stop bleeding from parenchy- matous organs in general surgery. It took more than two decades for this ingenious idea to be rediscovered. In 1940, Young and Medawar [8] reported on experimental nerve anastomosis by sealing. Similarly, Tarlov and Benjamin [7] reunited nerves with plasma clots in 1943. Tarlov improved the results obtained with clot anastomosing of nerves by avoiding tension at the nerve stumps. In 1944, Cronkite et al. [2] reported on an initial series of eight cases in which fibrinogen and thrombin had been used successfully for anchoring skin grafts. | | 出版日期 | Conference proceedings 1986Latest edition | | 關(guān)鍵詞 | aneurysm; blood; brain; bypass; cardiac surgery; general surgery; heart; lung; medicine; plasma; proliferation | | 版次 | 1 | | doi | https://doi.org/10.1007/978-3-642-71633-1 | | isbn_softcover | 978-3-540-17141-6 | | isbn_ebook | 978-3-642-71633-1 | | copyright | Springer-Verlag Berlin Heidelberg 1986 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國(guó)際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-8 07:41
發(fā)表于 2025-3-21 16:55:11
